Barclays Maintains Equal-Weight on BigCommerce Holdings, Lowers Price Target to $21
Barclays analyst Raimo Lenschow maintains BigCommerce Holdings (NASDAQ:BIGC) with a Equal-Weight and lowers the price target from $22 to $21.
Barclays Maintains Equal-Weight on Qualtrics International, Lowers Price Target to $16
Barclays analyst Raimo Lenschow maintains Qualtrics International (NASDAQ:XM) with a Equal-Weight and lowers the price target from $30 to $16.
Morgan Stanley Maintains Equal-Weight on Cummins, Lowers Price Target to $187
Morgan Stanley analyst Dillon Cumming maintains Cummins (NYSE:CMI) with a Equal-Weight and lowers the price target from $205 to $187.
Barclays Maintains Equal-Weight on WEC Energy Gr, Lowers Price Target to $104
Barclays analyst Eric Beaumont maintains WEC Energy Gr (NYSE:WEC) with a Equal-Weight and lowers the price target from $108 to $104.
Deutsche Bank Maintains Buy on MKS Instruments, Lowers Price Target to $125
Deutsche Bank analyst Sidney Ho maintains MKS Instruments (NASDAQ:MKSI) with a Buy and lowers the price target from $150 to $125.
Barclays Maintains Equal-Weight on SJW Gr, Lowers Price Target to $65
Barclays analyst Eric Beaumont maintains SJW Gr (NYSE:SJW) with a Equal-Weight and lowers the price target from $72 to $65.
Deutsche Bank Maintains Buy on KLA, Lowers Price Target to $385
Deutsche Bank analyst Sidney Ho maintains KLA (NASDAQ:KLAC) with a Buy and lowers the price target from $425 to $385.
Morgan Stanley Maintains Equal-Weight on Brinker International, Lowers Price Target to $26
Morgan Stanley analyst John Glass maintains Brinker International (NYSE:EAT) with a Equal-Weight and lowers the price target from $37 to $26.
Morgan Stanley Maintains Equal-Weight on Bloomin Brands, Lowers Price Target to $21
Morgan Stanley analyst John Glass maintains Bloomin Brands (NASDAQ:BLMN) with a Equal-Weight and lowers the price target from $26 to $21.
JP Morgan Maintains Overweight on Elanco Animal Health, Lowers Price Target to $32
JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from $37 to $32.